Acid-suppressive medications and risk of esophageal adenocarcinoma in patients with Barrett's esophagus: A systematic review and meta-analysis

被引：3
|
作者：
Singh, Preet Paul
Singh, Siddharth
Garg, Sushil Kumar
Iyer, Prasad G.
El-Serag, Hashem
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Univ Minnesota, Minneapolis, MN USA
[3] Baylor Coll Med, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 03期
关键词：
D O I：
10.1200/jco.2014.32.3_suppl.11
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Prevalence of Barrett's Esophagus and Esophageal Adenocarcinoma With and Without Gastroesophageal Reflux: A Systematic Review and Meta-analysis
    Saha, Bibek
    Vantanasiri, Kornpong
    Mohan, Babu P.
    Goyal, Rohit
    Garg, Nikita
    Gerberi, Danielle
    Kisiel, John B.
    Singh, Siddharth
    Iyer, Prasad G.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (07) : 1381 - 1394.e7
  • [22] Esophageal Adenocarcinoma in Barrett's Esophagus After Endoscopic Ablative Therapy: A Meta-Analysis and Systematic Review
    Wani, Sachin
    Puli, Srinivas R.
    Shaheen, Nicholas J.
    Westhoff, Brenda
    Slehria, Sanjeev
    Bansal, Ajay
    Rastogi, Amit
    Sayana, Hari
    Sharma, Prateek
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (02): : 502 - 513
  • [23] PREVALENCE OF BARRETT'S ESOPHAGUS AND ESOPHAGEAL ADENOCARCINOMA IN PATIENTS WITH AND WITHOUT GASTROESOPHAGEAL REFLUX SYMPTOMS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Saha, Bibek
    Vantanasiri, Kornpong
    Mohan, Babu P.
    Goyal, Rohit
    Garg, Nikita
    Gerberi, Danielle
    Singh, Siddharth
    Iyer, Prasad G.
    GASTROENTEROLOGY, 2023, 164 (06) : S1015 - S1016
  • [24] Circulating Levels of Inflammatory and Metabolic Biomarkers and Risk of Esophageal Adenocarcinoma and Barrett Esophagus: Systematic Review and Meta-analysis
    Xie, Shao-Hua
    Rabbani, Sirus
    Ness-Jensen, Eivind
    Lagergren, Jesper
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (11) : 2109 - 2118
  • [25] Phase I and II enzyme polymorphisms as risk factors for Barrett's esophagus and esophageal adenocarcinoma: a systematic review and meta-analysis
    Bull, L. M.
    White, D. L.
    Bray, M.
    Nurgalieva, Z.
    El-Serag, H. B.
    DISEASES OF THE ESOPHAGUS, 2009, 22 (07) : 571 - 587
  • [26] Meta-Analysis of the Risk of Esophageal Adenocarcinoma in Non-Dysplastic Barrett's Esophagus
    Desai, Tusar K.
    Krishnan, Kumar
    Samala, Niharika R.
    Cluley, John D.
    Howden, Colin W.
    GASTROENTEROLOGY, 2011, 140 (05) : S223 - S223
  • [27] Incidence of esophageal adenocarcinoma in Barrett's esophagus with low-grade dysplasia: a systematic review and meta-analysis
    Singh, Siddharth
    Manickam, Palaniappan
    Amin, Anita V.
    Samala, Niharika
    Schouten, Leo J.
    Iyer, Prasad G.
    Desai, Tusar K.
    GASTROINTESTINAL ENDOSCOPY, 2014, 79 (06) : 897 - U248
  • [28] Development of Esophageal Adenocarcinoma in Patients with Barrett's Esophagus and High Grade Dysplasia Undergoing Survilence: A Meta-Analysis and Systematic Review
    Puli, Srinivas R.
    Rastogi, Amit
    Mathur, Sharad
    Bansal, Ajay
    Sharma, Prateek
    GASTROINTESTINAL ENDOSCOPY, 2006, 63 (05) : AB83 - AB83
  • [29] Statins Are Associated With Reduced Risk of Esophageal Cancer, Particularly in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis
    Singh, Siddharth
    Singh, Abha Goyal
    Singh, Preet Paul
    Murad, Mohammad Hassan
    Iyer, Prasad G.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (06) : 620 - 629
  • [30] Acid-suppressive agents and survival outcomes in patients with cancer: a systematic review and meta-analysis
    Hyun Jin Song
    Kiyon Rhew
    Yoon Jae Lee
    In-Hyuk Ha
    International Journal of Clinical Oncology, 2021, 26 : 34 - 50
12345